68 related articles for article (PubMed ID: 7590608)
1. [Production of HTLV-II env protein and its suppressive effect on infection].
Kawamura N
Hokkaido Igaku Zasshi; 1995 Jul; 70(4):635-47. PubMed ID: 7590608
[TBL] [Abstract][Full Text] [Related]
2. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
[TBL] [Abstract][Full Text] [Related]
3. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
4. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
5. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
6. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
7. Evidence in Gabon for an intrafamilial clustering with mother-to-child and sexual transmission of a new molecular variant of human T-lymphotropic virus type-II subtype B.
Tuppin P; Gessain A; Kazanji M; Mahieux R; Cosnefroy JY; Tekaia F; Georges-Courbot MC; Georges A; de Thé G
J Med Virol; 1996 Jan; 48(1):22-32. PubMed ID: 8825706
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
9. Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.
Noraz N; Benichou S; Madaule P; Tiollais P; Vernant JC; Desgranges C
Virology; 1993 Mar; 193(1):80-8. PubMed ID: 7679862
[TBL] [Abstract][Full Text] [Related]
10. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
[TBL] [Abstract][Full Text] [Related]
12. Rapid generation of antibodies against the HTLV-II external envelope protein by growth of mouse plasmacytomas in SCID mice.
Li QX; Camerini D; Kuritzkes DR; Chen IS
Virology; 1995 Dec; 214(2):680-4. PubMed ID: 8553576
[TBL] [Abstract][Full Text] [Related]
13. [Expression of a fragment of the env gene, coding for the GP46 surface glycoprotein of the human T-cell leukemia virus, in Escherichia coli cells].
Bondarenko VO; Kazennova EV; Bobkova MR; Prilipov AG; Bobkov AF
Mol Gen Mikrobiol Virusol; 2000; (3):33-6. PubMed ID: 10975079
[TBL] [Abstract][Full Text] [Related]
14. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
15. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
Costa JM; Segurado AC
J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
[TBL] [Abstract][Full Text] [Related]
16. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
Tanaka Y; Tanaka R; Hoshino H
Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496
[TBL] [Abstract][Full Text] [Related]
18. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
[TBL] [Abstract][Full Text] [Related]
19. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
Lal RB; Rudolph DL; Kaplan JE; Hjelle B; Levine PH; Coligan JE; Viscidi RP
Virology; 1992 Jan; 186(1):274-9. PubMed ID: 1727602
[TBL] [Abstract][Full Text] [Related]
20. Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients.
Lin MT; Nguyen BT; Binh TV; Be TV; Chiang TY; Tseng LH; Yang YC; Lin KH; Chen YC
Arch Virol; 1997; 142(7):1429-40. PubMed ID: 9267453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
